Trethera

Sherman Oaks, CA · Founded 2015 · Privately Held (backing)

Developer of nucleotide metabolism drugs designed to provide treatment for cancer and autoimmune diseases. Trethera is based in Sherman Oaks, CA and was founded in 2015. Its last reported valuation was $13.1 million in Apr 2019. It has raised $35 million across 7 recorded rounds; the latest was a $250,000 seed round in Apr 2025.

Last reported valuation
$13.1M
Oct 2026
Priced at
—
Total raised
$35.0M
Last round
Seed Round
Apr 2025

Who backs Trethera?

7 investors
InvestorType
National Institutes of HealthOther
Libertatis Ergo Holding (LEH)—
LifeSciences@Work—
National Cancer Institute—
National Eye Institute—
National Institute Of Allergy and Infectious Diseases—
unlock_—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Trethera investors

7 investors are on record for Trethera, including National Institutes of Health, Libertatis Ergo Holding (LEH), LifeSciences@Work and National Cancer Institute. The seed round in Apr 2025 drew 1 investor.

Free account
More of Trethera with a free account
  • ·Watch Trethera: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 7 firms already write checks for companies like Trethera. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View